C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men
Open Access
- 28 July 2004
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 47 (8) , 1403-1410
- https://doi.org/10.1007/s00125-004-1472-x
Abstract
Low-grade inflammation has been implicated in the development of Type 2 diabetes and cardiovascular disease, but its role in the pathogenesis of the metabolic syndrome is unclear. We investigated the association between C-reactive protein (CRP) levels and the development of the metabolic syndrome and diabetes in men.Keywords
This publication has 46 references indexed in Scilit:
- C-Reactive Protein and the Risk of Developing HypertensionJAMA, 2003
- Elevated C-Reactive Protein Is a Risk Factor for the Development of Type 2 Diabetes in Japanese AmericansDiabetes Care, 2003
- Habitual Dietary Intake of n-3 and n-6 Fatty Acids in Relation to Inflammatory Markers Among US Men and WomenCirculation, 2003
- Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese WomenJAMA, 2003
- Metabolic Syndrome and Development of Diabetes Mellitus: Application and Validation of Recently Suggested Definitions of the Metabolic Syndrome in a Prospective Cohort StudyAmerican Journal of Epidemiology, 2002
- Do atherosclerosis and type 2 diabetes share a common inflammatory basis?European Heart Journal, 2002
- Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged womenThe American Journal of Clinical Nutrition, 2002
- Fibrinogen, Other Putative Markers of Inflammation, and Weight Gain in Middle‐aged Adults—The ARIC StudyObesity Research, 2000
- 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.1999
- Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO ConsultationDiabetic Medicine, 1998